Richardson H, Grosset KA, Leuthold H, Grosset DG
Eur J Neurol 13 (S2) : 82
Background and aims: Tremor is the commonest wearing off symptom after a dose of medication in Parkinson s disease (PD). Ambulatory accelerometry is validated for continuous tremor measurement in PD, typically during standardised conditions such as out-patient hospital attendance, or for periods up to 24 hours. We have developed and tested a miniaturised accelerometer device which prolongs recording-duration to 6 days. Methods: A dual-axis accelerometer device (half the size of a credit card) was worn in a wrist-band on the tremor dominant arm (ActivPal, Glasgow, UK). Sampling occurred at 20 Hertz. Hourly changes in motor status were recorded for 3 days using a standard Parkinson s disease symptom diary, supplemented with a visual analogue record of tremor severity. Results: In 3 patients with fluctuating tremor as a component of idiopathic PD, mean age 70 years, disease duration 7 years, and antiparkinson therapy duration 5 years, consisting of levodopabased treatment in 1 case, dopamine agonist treatment in 1 case, and combination therapy in 1 case, successful recording of 6 days of tremor was achieved. Tremor fluctuation was captured and the characteristically reduced tremor overnight was readily identified. Daytime fluctuations were clearly evident, and artefact filtering improved signal quality by combining tremor traces from the 2 channels. Fourier transformation identified the 3 4 Hz tremor classic of PD. Conclusions: Out-patient ambulatory tremor monitoring is achievable with a high sampling rate and offers potential to increase precision in testing drug effects in Parkinson s disease.Richardson H, Grosset KA, Leuthold H, Grosset DG Assessment Of Fluctuating Tremor Using Miniaturised And Prolonged Ambulatory Accelerometry Eur J Neurol 13 (S2) : 82 2006. http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2006.01621.x/abstract.